For example, expression of the marker CD24 has been used to distinguish between different cancer cell phenotypes, where enhanced tumor-initiating potential correlates with residence in a CD44HiCD24Lo state and the CD44HiCD24Hi cell state is further associated with tolerance to chemotherapy [61]. This evidence concerns the gene CD24 and neoplasm.